Abstract
This study examines the implementation of naloxone distribution initiatives in Pennsylvania public libraries following a nationwide program offering free Narcan. We conducted a cross-sectional telephone survey with a random sample of Pennsylvania public libraries (n=352). Overall, nearly one-quarter of respondents reported stocking naloxone (23.9%), and over one in ten libraries reported a previous on-site overdose (11.9%). Nearly 30% of respondents had received naloxone training. Significant predictors of on-site overdoses included the library’s county urbanization status and higher county-level overdose mortality rates. Among libraries that stocked naloxone, 73% obtained the medication from local health departments or community-based organizations. This study underscores the role of public libraries in opioid overdose crisis response and the need for tailored strategies to enhance naloxone accessibility, especially in high-risk urban areas. Collaboration between libraries, public health entities, and pharmaceutical companies is crucial to amplify naloxone distribution efforts and address the escalating opioid overdose crisis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board University of Pennsylvania
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
A limited dataset produced in the present study is available upon reasonable request to the authors
